Updated Jul 16, 2026
Bertrand William C JR has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $2K.

| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | ARDX | ARDELYX, INC. | A — Grant or award | 26.5K | $0.00 | |
| 2026-06-18 | ARDX | ARDELYX, INC. | A — Grant or award | 12.3K | $0.00 | |
| 2025-08-28 | ADAP | Adaptimmune Therapeutics PLC | S — Open-market sale | 207.0K | $0.01 | $2K |
| 2025-06-18 | ARDX | ARDELYX, INC. | A — Grant or award | 41.6K | $0.00 | |
| 2025-06-18 | ARDX | ARDELYX, INC. | A — Grant or award | 19.4K | $0.00 |
Bertrand William C JR is a corporate insider — currently tracked as Director of ARDELYX, INC. (ARDX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($2K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bertrand William C JR profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.